DarioHealth Historical Income Statement
| DRIO Stock | USD 0.83 0.05 6.41% |
Historical analysis of DarioHealth Corp income statement accounts such as Selling General Administrative of 9.6 M or Selling And Marketing Expenses of 13.6 M can show how well DarioHealth Corp performed in making a profits. Evaluating DarioHealth Corp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DarioHealth Corp's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining DarioHealth Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DarioHealth Corp is a good buy for the upcoming year.
DarioHealth |
About DarioHealth Income Statement Analysis
DarioHealth Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DarioHealth Corp shareholders. The income statement also shows DarioHealth investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
DarioHealth Corp Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of DarioHealth Corp. It is also known as DarioHealth Corp overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from DarioHealth Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DarioHealth Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.At this time, DarioHealth Corp's Interest Income is very stable compared to the past year. As of the 22nd of November 2024, Reconciled Depreciation is likely to grow to about 5.2 M, while Selling General Administrative is likely to drop about 9.6 M.
DarioHealth Corp income statement Correlations
Click cells to compare fundamentals
DarioHealth Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DarioHealth Corp income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 203K | 457K | 3.5M | 3.8M | 5.0M | 5.2M | |
| Interest Expense | 27K | 49K | 84K | 1.9M | 645K | 677.3K | |
| Selling General Administrative | 5.5M | 12.8M | 23.5M | 16.5M | 18.1M | 9.6M | |
| Selling And Marketing Expenses | 11.1M | 15.2M | 39.7M | 30.3M | 23.8M | 13.6M | |
| Other Operating Expenses | 25.3M | 37.5M | 97.0M | 84.5M | 76.5M | 80.4M | |
| Operating Income | (17.7M) | (29.9M) | (76.5M) | (56.8M) | (56.2M) | (53.4M) | |
| Ebit | (17.7M) | (30.2M) | (76.6M) | (60.6M) | (58.5M) | (55.6M) | |
| Research Development | 3.7M | 4.4M | 17.2M | 19.6M | 20.2M | 21.3M | |
| Ebitda | (17.5M) | (29.7M) | (73.1M) | (56.8M) | (53.5M) | (50.8M) | |
| Total Operating Expenses | 20.3M | 32.4M | 80.5M | 66.5M | 62.2M | 31.2M | |
| Income Before Tax | (17.7M) | (29.4M) | (76.7M) | (62.2M) | (59.4M) | (56.4M) | |
| Total Other Income Expense Net | (31K) | 458K | (235K) | (5.4M) | (3.2M) | (3.0M) | |
| Net Income | (17.8M) | (29.0M) | (76.8M) | (62.2M) | (59.4M) | (56.5M) | |
| Income Tax Expense | 31K | (458K) | 32K | 4K | 64K | 60.8K | |
| Total Revenue | 7.6M | 7.6M | 20.5M | 27.7M | 20.4M | 21.4M | |
| Gross Profit | 2.6M | 2.5M | 4.0M | 9.7M | 6.0M | 6.3M | |
| Net Income From Continuing Ops | (17.7M) | (29.4M) | (76.8M) | (62.2M) | (57.8M) | (54.9M) | |
| Cost Of Revenue | 5.0M | 5.1M | 16.6M | 18.0M | 14.4M | 8.9M | |
| Non Operating Income Net Other | (31K) | 458K | (235K) | (5.4M) | (4.8M) | (4.6M) | |
| Net Income Applicable To Common Shares | (20.9M) | (33.1M) | (78.8M) | (62.2M) | (56.0M) | (53.2M) | |
| Interest Income | 16K | 61K | 44K | 506K | 1.7M | 1.8M | |
| Net Interest Income | (11K) | 12K | (40K) | (2.2M) | (820K) | (779K) | |
| Reconciled Depreciation | 183K | 190K | 3.3M | 4.7M | 4.9M | 5.2M |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.65 | GH | Guardant Health | PairCorr |
| 0.56 | LH | Laboratory | PairCorr |
| 0.37 | CAH | Cardinal Health | PairCorr |
| 0.33 | ELAB | Elevai Labs, Common | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 0.631 | Quarterly Revenue Growth 1.11 | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.